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ABSTRACT
Objective To assess pharmacy workers’
knowledge and provision of abortion information
and methods in Kenya.
Methods In 2013 we interviewed 235
pharmacy workers in Nairobi, Mombasa and
Kisumu about the medical abortion services they
provide. We also used mystery clients, who made
401 visits to pharmacies to collect first-hand
information on abortion practices.
Results The majority (87.5%) of pharmacy
workers had heard of misoprostol but only
39.2% had heard of mifepristone. We found
that pharmacy workers had limited knowledge of
correct medical abortion regimens, side effects
and complications and the legal status of
abortion drugs. 49.8% of pharmacy workers
reported providing abortion information to
clients and 4.3% reported providing abortion
methods. 75.2% of pharmacies referred mystery
clients to another provider, though 64.2% of
pharmacies advised mystery clients to continue
with their pregnancy. Pharmacy workers reported
that they were experiencing demand for abortion
services from clients.
Conclusions Pharmacy workers are important
providers of information and referrals for women
seeking abortion, however their medical abortion
knowledge is limited. Training pharmacy workers
on medical abortion may improve the quality of
information provided and access to safe
abortion.
INTRODUCTION
Twenty-two million pregnancies are termi-
nated unsafely each year, nearly all in
developing countries.1 Rates are highest
in East Africa; unsafe abortions in Kenya
result in 2600 deaths of women and girls
annually, accounting for 35% of maternal
deaths.2 In 2010, Kenya passed a new
constitution that made abortion
permissible if “in the opinion of a trained
health professional, there is need for
emergency treatment, or the life or health
of the mother is in danger, or if permitted
by any other written law”.3 Although the
law does not provide the definition of a
trained health care professional, the con-
stitution is generally taken to refer to
medical doctors, nurses, clinical officers
and trained midwives. However, the
Kenyan Penal Code has yet to be revised
in line with the new constitution and
many health practitioners may be unin-
formed about their legal status and hesi-
tant to provide abortions.2
Medical abortion (MA), using mifepris-
tone and misoprostol, is a safe, effective
alternative to surgical abortion.4
Misoprostol can also be used on its own
when mifepristone is not available, though
it is a less effective option. Availability of
these drugs in Kenya is largely limited to
private clinics and pharmacies. Pharmacy
workers, including pharmacists, can
inform clients of methods and offer refer-
rals, but abortion medications can only be
legally obtained when supplied against a
valid prescription.
Key message points
▸ Pharmacy workers in Kenya play an
important role in providing medical abor-
tion (MA) information and referrals.
▸ Pharmacy workers’ knowledge of MA
drugs and registration status is limited,
and there are gaps in the information
they provide to clients.
▸ Training is required to ensure effective
and high-quality MA information and
drug provision and to expand access to
safe abortion.
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Globally, evidence demonstrates that men and
women go to pharmacies to seek abortion, as pharma-
cies are relatively easy to access and offer anonymity.5 6
Pharmacies in Kenya therefore have an important role
in ensuring clients are aware of available options, pro-
viding referrals, and dispensing MA products safely
when presented with a prescription.
Previous studies have examined pharmacy provision
of health services in Nairobi7–9 but little is known
about pharmacy provision of MA across Kenya. This
study sought to generate evidence on pharmacy
workers’ (including pharmacists, technicians, assistants
and any pharmacy worker providing customer
support) knowledge and provision of abortion services
in Kenya. The specific objectives were: (1) to assess
pharmacy workers’ knowledge of mifepristone and/or
misoprostol for MA and (2) to examine self-reported
and actual provision of abortion information and
methods among pharmacy workers.
METHODS
Data collection
In April and May 2013, two methodologies were used
to collect data on MA knowledge and provision
among pharmacy workers in the three largest cities in
Kenya: Nairobi, Mombasa and Kisumu. First, a struc-
tured survey was conducted among pharmacy
workers. In each city, 100 pharmacies were sampled
from a list of all registered private pharmacies yielding
a total sample of 300 pharmacies. Selection criteria
for study participants included dispensing medicines
and having worked at the pharmacy for at least
6 months. Pharmacy workers were asked to give
informed consent prior to being interviewed by a
trained research assistant. One interview was con-
ducted per outlet, during which pharmacy workers
were asked about their training, knowledge of abor-
tion services and the information and methods they
provide.
As interview responses do not always reflect real-life
practice, mystery client surveys were also conducted.
Twelve women aged between 17 and 31 years visited
pharmacies posing as clients seeking an abortion
service without a prescription. The fieldworkers
received 2 days of training in which they practised
role-playing and giving standardised responses.
Informed consent was obtained from the proprietor
of each pharmacy for mystery client visits in the
ensuing 6 months. A total of 138 pharmacies were
visited by mystery clients, including 104 pharmacies
that participated in the pharmacy worker survey. In
total, 401 mystery client visits were conducted. Each
pharmacy was visited an average of three times, by
different mystery clients on different dates at least
3 days apart and at least 1 week after the pharmacy
worker survey. Within 1 hour of each visit, the
mystery client completed a structured questionnaire.
Ethical approval
Ethical approval was obtained from the Ethics Review
Committee of the Kenya Medical Research Institute,
the Institutional Review Board of the Population
Council and the Marie Stopes International Ethics
Review Committee.
Data analysis
Data were analysed descriptively. Pharmacy workers
were asked about the type of information provided to
clients seeking abortion services, and were then cate-
gorised as non-providers or providers of information.
Non-providers included individuals who did not provide
any information other than advising against termination,
while those who referred clients to health facilities, gave
information on abortion methods, and/or advised clients
to seek counselling were counted as providers of infor-
mation, whether or not they also advised against termin-
ation. In the mystery client survey, pharmacy workers
were considered to be providers of information or
methods if they provided MA information or methods
to any of the mystery clients that visited their pharmacy.
RESULTS
Pharmacy worker survey respondents
Out of 300 pharmacies sampled, 26 could not be
traced because they had closed or moved premises.
The remaining 274 pharmacies were invited to partici-
pate in the survey; 235 structured interviews were
completed. Pharmacy workers at 39 sampled outlets
declined to participate, yielding a response rate of
86%.
The mean age of respondents was 31 years, and
51.5% of respondents were male (Table 1).
Knowledge and training of pharmacy workers on MA
A higher proportion of pharmacy workers had heard
of misoprostol than mifepristone (87.5% vs 39.2%)
and were able to report a correct misoprostol-only
regimen than a combined mifepristone-misoprostol
regimen for medical termination (19.3% vs 9.2%).
Among respondents who reported having heard of
misoprostol, 18.3% were unable to name any side
effects and 17.8% were unable to name any complica-
tions of its use for abortion. Some 72% mentioned
excessive bleeding as a complication, but only 15.3%
mentioned infection and 22.8% mentioned the risk of
incomplete abortion. Respondents were also asked for
which conditions misoprostol is registered; respon-
dents named peptic ulcers (72.3%), labour induction
(34.7%), pregnancy termination (30.2%), postpartum
haemorrhage (14.4%) and post-abortion care (6.9%).
The proportion of pharmacy workers who had
received abortion training was low (13.7%). Training
on misoprostol-only was more common (53.1%) than
mifepristone-misoprostol combined (three respon-
dents; 6.3%). Abortion training was received from a
university or medical college (71.9%) or
Research
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non-governmental organisation (25.0%). Nearly half
(45.5%) the respondents wanted more information or
training on abortion services. The most commonly
requested training topics among this group included
training on MA methods (66.7%), legal and policy
provisions around abortion (49.5%), and recognition
and management of complications (31.4%).
Provision practices of pharmacy workers
Just under half (49.8%) of pharmacy workers reported
providing information on abortion to clients during the
structured survey. The most common information pro-
vided was a referral to a health facility (41.3%). Ten
pharmacy workers reported providing information on
methods (two medical, six surgical, two not specified).
Only 10 (4.3%) pharmacy workers reported that they
provided MA methods. Of these, data was missing for
one pharmacy worker; the remaining nine (3.8%)
reported offering misoprostol-only MA. Seventy-four
pharmacy workers (31.5%) reported that they stocked
MA drugs, but more commonly misoprostol (100%)
than mifepristone (2.7%).
Provision of information on abortion methods was
more common in mystery client visits than in self-
report; 62.1% of pharmacies gave information about
surgical methods in one or more of the encounters,
and 53.7% gave information about medical methods.
Information about medical methods was usually
limited to misoprostol-only (51.5%) rather than
mifepristone-misoprostol combined (6.3%) (Table 2).
Misoprostol was offered to mystery clients by a
total of 28 pharmacies (25.7%) and mifepristone-
misoprostol combined was offered by three pharma-
cies (2.8%). Additionally, surgical methods were
offered by 25 (26.6%) pharmacies. While information
on how to use the medication was provided by 89.3%
of these 28 pharmacies, they were less likely to
inform clients about side effects (59.8%), complica-
tions (55.1%), when (31.1%) and where (31.5%) to
seek help in case of complications, and effectiveness
of the drug (50.6%). The option of family planning
was discussed or recommended to clients in only five
encounters.
Demand for abortion services
Of the 119 (50.6%) pharmacy workers who reported
providing abortion information or methods, the mean
reported monthly number of women seeking abortion
was 12. Of 101 (42.9%) pharmacy workers who
reported not providing information or termination
methods to women seeking abortion, 74% reported
that clients ask for these services.
DISCUSSION
Pharmacy workers often serve as frontline providers
of health care, and those who participated in the
study reported that they experienced a demand for
Table 2 Medical abortion provision practices
Methodology
Structured survey
Mystery client pharmacies
(Total n=235)
(Total n=138)
% Total n* %
Do not provide any information or advice 49.4 136 16.9
Provide information or advice on abortion services 49.8 136 83.1
Gave information on abortion methods 4.3 130 61.5
Provide methods of abortion 4.3 97 42.3
*Total n supplied for each variable due to missing data in the mystery client survey.
Table 1 Characteristics of pharmacy workers in the structured
survey (n=235)
Total
Characteristic [n (%)]
Location
Urban 80 (34.3)
Peri-urban 130 (55.8)
Rural 23 (9.9)
Gender
Male 120 (51.5)
Female 113 (48.5)
Age (years)
22–27 66 (29.6)
28–34 115 (51.6)
35+ 42 (18.8)
Education
Secondary education 15 (6.5)
College 190 (81.9)
University 27 (11.6)
Training received to dispense medicines
No training received 11 (4.8)
Training received 217 (95.2)
Abortion training received*
No training received 202 (86.3)
Training received 32 (13.7)
Medical methods 17 (53.1)
Surgical methods 22 (68.8)
Clinic size (staff ) (n)
1–2 54 (23.3)
3–5 122 (52.6)
6+ 56 (24.1)
*Including a one-to-one discussion on the topic or a group training event.
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abortion services. It is important that pharmacy
workers have adequate knowledge of MA so that they
can correctly inform clients without a prescription of
their options, and can provide clients with a prescrip-
tion with the information and products they need.
The survey revealed a lack of knowledge among phar-
macy workers about correct regimens for MA drugs,
their registration status, potential side effects and
abortion complications. This is not surprising consid-
ering the low proportion of pharmacy workers who
had received any form of abortion training.
Pharmacy workers offered MA methods without
prescription to mystery clients on some occasions.
Most mystery clients who were offered misoprostol
for MAwere not informed about side effects, abortion
complications or about contraceptive methods. These
findings are consistent with a mystery client survey
undertaken in Nairobi in 2008, which found that
12% of pharmacy workers were willing to dispense
misoprostol for abortion but instructions for its use
were very poor.7 The findings also reflect practices in
other locations: provision of inaccurate, incomplete
MA information by untrained pharmacy workers has
been documented globally.10–15
In Kenya, training pharmacy workers on MA
methods and information, and contraceptive counsel-
ling for MA clients, may be an effective strategy to
reduce the incidence of unsafe abortion. Almost half
the pharmacy workers interviewed wanted more train-
ing on abortion. Pharmacy workers should also
receive training on referrals, to ensure adequate col-
laboration between pharmacy workers and medical
practitioners. Finally, training could cover the registra-
tion status of MA drugs and the legal framework for
providing MA. This may prevent women being turned
away from pharmacies and resorting to unregistered
vendors, where the risk of receiving inadequate infor-
mation is likely to be higher.16 Further research is
needed to better understand the barriers that prevent
pharmacy workers from providing MA services and to
evaluate the effectiveness of different training regi-
mens in encouraging safe, high quality pharmacy pro-
vision of abortion information and methods within
existing legal standards.
This study is the first to use pharmacy worker inter-
views and mystery client surveys to triangulate evi-
dence on MA knowledge and service provision in
multiple locations across Kenya. The study has a
number of limitations. Registered pharmacies were
sampled, thus excluding informal drug sellers who
may be more likely to provide abortion services. Some
of the pharmacies that were sampled for each compo-
nent (survey and mystery client visit) were not the
same. In addition, where the same pharmacy was
included in both components, it is possible that the
pharmacy worker interviewed was the not the one
who interacted with the mystery clients. The number
of mystery clients varied by pharmacy, meaning that
detection of provision of abortion was more likely in
those pharmacies that received a higher number of
visits. The information gained from the pharmacy
worker survey may be subject to recall bias and under-
reporting due to the sensitive nature of the topic.
Additionally, it was not possible to determine whether
the practices of interviewees were based on personal
practice or the wider policy of the pharmacy. There
was also potential for misreporting or recall bias on
the part of the mystery client, although this was mini-
mised through immediate completion of a structured
survey after the encounter. It is possible that pharma-
cies amended their practices because they were aware
that a mystery client would be visiting, though this
risk was minimised as pharmacy workers were not
told of the exact date when such visits might occur
within a 6-month period.
In conclusion, pharmacy workers have the potential
to expand access to safe MA in Kenya and they play
an important role in providing abortion information
and referrals. Knowledge of MA drugs and their regis-
tration status is limited, and provision of MA methods
is low, although this could be at least in part due to
under-reporting for fear of legal repercussions.
Training is required to ensure effective and high-
quality MA information and method provision and to
expand access to safe abortion within existing legal
standards.
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